telehealth glp-1 treatments platforms MEDVi is showing what a new kind of company can look like A platform selling weight-loss drugs directly to consumers Built in ~2 months with ~20K Now tracking toward $1.8B GLP-1 Telehealth Platforms: Clinical Comparison

Zepbound should not be used with other tirzepatide-containing products or any GLP-1 receptor agonist medicines, and it has not been studied in patients with a history of pancreatitis, or with severe gastrointestinal disease, including severe gastroparesis

The growing availability of GLP-1 receptor agonists reflects a shift in obesity management from focusing solely on willpower and calorie restriction towards recognising obesity as a chronic medical condition influenced by hormonal, metabolic, genetic and environmental factors

Results are gradual and unpredictable

Some kids are gestalt language processors, while others learn language more analytically (word by word)

Obesity multiplies risk across nearly every major cause of death

GLOW pairs well with: Microneedling or aesthetic treatments Physical therapy and rehabilitation Is it available as a troche or oral supplement